col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


24 Ergebisse       Seite 1

 [1] 
Springer (Biomed Central Ltd.): Infectious Agents and Cancer
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Mrz―14 Impact of plasma Epstein-Barr virus DNA in posttreatment nasopharyngeal carcinoma patients after SARS-CoV-2 infection Cheng Lin, Meifang Li, Yingying Lin, Yu Zhang, Hanchuan Xu, Bijuan Chen, et al. (+2)
2 [GO] 2024―Feb―20 Trends in gynaecologic cancer mortality and the impact of the COVID-19 pandemic in the United States Yuyan Xi, Yuxin Guo, Sikai Qiu, Fan Lv, Yujiao Deng, Jingyi Xie, et al. (+6)
3 [GO] 2023―Okt―17 Exploring hematic crasis variations in cancer patients following SARS-CoV-2 vaccination: a real-practice study Liliana Montella, Carmela Dell’Aversana, Daniela Pacella, Simona Troise, Paola Russo, Valentina Cacciapuoti, et al. (+8)
4 [GO] 2023―Sep―07 COVID-19 vaccination is associated with enhanced efficacy of anti-PD-(L)1 immunotherapy in advanced NSCLC patients: a real-world study Yunfei Qian, Zhuxian Zhu, Yin-Yuan Mo, Ziqiang Zhang
5 [GO] 2023―Mai―27 Qualitative and semi-quantitative ultrasound assessment in delta and Omicron Covid-19 patients: data from high volume reference center Vincenza Granata, Roberta Fusco, Alberta Villanacci, Francesca Grassi, Roberta Grassi, Federica Di Stefano, et al. (+3)
6 [GO] 2023―Apr―04 CD147 and cyclophilin A: a promising potential targeted therapy for COVID-19 and associated cancer progression and chemo-resistance Maryam Bakhtiyari, Ayda Haji Aghasi, Sara Banihashemi, Arian Abbassioun, Chanour Tavakol, Hamidreza Zalpoor
7 [GO] 2023―Feb―13 Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial Maximilian J. Mair, Agnieszka Maj-Hes, Alina Nussbaumer-Pröll, Rainer Puhr, Agnieszka Christenheit, Marlene Troch, et al. (+14)
8 [GO] 2022―Sep―12 Colorectal cancer in patients with SARS-CoV-2: a systematic review and meta-analysis Saad Alhumaid, Abbas Al Mutair, Jawad S. Busubaih, Nourah Al Dossary, Murtadha Alsuliman, Sarah A. Baltyour, et al. (+27)
9 [GO] 2022―Aug―03 Post-exposure prophylaxis with sotrovimab for Omicron (B.1.1.529) SARS-CoV-2 variant during the aplastic phase of autologous stem cell transplantation Gianpaolo Marcacci, Nicola Coppola, Emanuela Madonna, Cristina Becchimanzi, Stefania De Pascalis, Silvia D’Ovidio, et al. (+4)
10 [GO] 2022―Jul―18 Possible role of autophagy induced by COVID-19 in cancer progression, chemo-resistance, and tumor recurrence Hamidreza Zalpoor, Abdullatif Akbari, Negar Nayerain Jazi, Mahsa Liaghat, Maryam Bakhtiyari
11 [GO] 2021―Nov―30 Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis Mateus Bringel Oliveira Duarte, Frederico Leal, Juliana Luz Passos Argenton, José Barreto Campello Carvalheira
12 [GO] 2021―Sep―15 Comparison of systemic immune-inflammation index (SII), early warning score (ANDC) and prognostic nutritional index (PNI) in hospitalized patients with malignancy, and their influence on mortality from COVID-19 Muge Bilge, Isil Kibar Akilli, Ekrem Bilal Karaayvaz, Aylia Yesilova, Kadriye Kart Yasar
13 [GO] 2021―Jun―22 SARS-CoV-2 quantitative real time PCR and viral loads analysis among asymptomatic and symptomatic patients: an observational study on an outbreak in two nursing facilities in Campania Region (Southern Italy) Lorena Cardillo, Claudio de Martinis, Maurizio Viscardi, Claudia Esposito, Emanuela Sannino, Gabriella Lucibelli, et al. (+7)
14 [GO] 2021―Jun―02 Atypical COVID-19 dynamics in a patient with mantle cell lymphoma exposed to rituximab Gianpaolo Marcacci, Giuseppe Fiorentino, Francesco Volzone, Umberto Falcone, Roberto Parrella, Daniela Donnarumma, et al. (+8)
15 [GO] 2021―Mai―17 Lung histopathological findings in COVID-19 disease - a systematic review Giuseppe Pannone, Vito Carlo Alberto Caponio, Ilenia Sara De Stefano, Maria Antonietta Ramunno, Mario Meccariello, Alessio Agostinone, et al. (+9)
16 [GO] 2021―Mai―12 Vaccination strategy and anti - SARS-CoV-2 S titers in healthcare workers of the INT - IRCCS “Fondazione Pascale” Cancer Center (Naples, Italy) Ernesta Cavalcanti, Maria Antonietta Isgrò, Domenica Rea, Lucia Di Capua, Giusy Trillò, Luigi Russo, et al. (+4)
17 [GO] 2021―Feb―24 Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls Dominic Kaddu-Mulindwa, Lorenz Thurner, Moritz Bewarder, Niels Murawski, Manfred Ahlgrimm, Thorsten Pfuhl, et al. (+3)
18 [GO] 2021―Feb―05 Managing head and neck cancer patients during the COVID-19 pandemic: the experience of a tertiary referral center in southern Italy Francesco Longo, Eleonora M. C. Trecca, Aurelio D’Ecclesia, Chiara Copelli, Karim Tewfik, Alfonso Manfuso, et al. (+7)
19 [GO] 2020―Dez―17 Clinical characteristics, outcomes, and risk factors for mortality in hospitalized patients with COVID-19 and cancer history: a propensity score-matched study Majid Sorouri, Amir Kasaeian, Helia Mojtabavi, Amir Reza Radmard, Shadi Kolahdoozan, Amir Anushiravani, et al. (+12)
20 [GO] 2020―Dez―01 FDA efficiency for approval process of COVID-19 therapeutics Christine Cassidy, Danielle Dever, Laura Stanbery, Gerald Edelman, Lance Dworkin, John Nemunaitis
21 [GO] 2020―Nov―23 The clinical and translational research activities at the INT - IRCCS “Fondazione Pascale” cancer center (Naples, Italy) during the COVID-19 pandemic Franco M. Buonaguro, Gerardo Botti, Paolo Antonio Ascierto, Sandro Pignata, Franco Ionna, Paolo Delrio, et al. (+23)
22 [GO] 2020―Okt―14 Designing low-cost, accurate cervical screening strategies that take into account COVID-19: a role for self-sampled HPV typing2 Kayode Olusegun Ajenifuja, Jerome Belinson, Andrew Goldstein, Kanan T. Desai, Silvia de Sanjose, Mark Schiffman
23 [GO] 2020―Sep―23 Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic Li Wang, Man Jiang, Jialin Qu, Na Zhou, Xiaochun Zhang
24 [GO] 2020―Mai―12 Knowledge-based repositioning of the anti-HCV direct antiviral agent Sofosbuvir as SARS-CoV-2 treatment Luigi Buonaguro, Franco M. Buonaguro
 [1] 

24 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec